Your shopping cart is currently empty

STAT3/AKT-IN-1 is a dual inhibitor of the signal transducer and activator of transcription 3 (STAT3) and protein kinase B (AKT) signaling pathways, demonstrating anti-tumor activity and inducing apoptosis in SGC-7901 cells.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | STAT3/AKT-IN-1 is a dual inhibitor of the signal transducer and activator of transcription 3 (STAT3) and protein kinase B (AKT) signaling pathways, demonstrating anti-tumor activity and inducing apoptosis in SGC-7901 cells. |
| In vitro | STAT3/AKT-IN-1 inhibits the viability of gastric cancer cells SGC-7901 and BGC-823, with IC50 values of 1.39 μM and 2.92 μM, respectively. At concentrations ranging from 2.5 to 10 μM, STAT3/AKT-IN-1 dose-dependently induces G2/M phase cell cycle arrest, suppresses proliferation and migration of SGC-7901 cells, and triggers apoptosis. |
| In vivo | Administered intravenously at a dose of 15 mg/kg once daily for 20 days, STAT3/AKT-IN-1 demonstrates anticancer activity with no significant toxicity in SGC-7901 xenograft BALB/c mice. |
| Formula | C23H22O4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.